Contineum Therapeutics Inc
For the period ended Mar 31, 2024. Filed May 16, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 16, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Other Information
Item5. Other Information.
(c) Securities Trading Plans of Directors and Executive Officers
During the quarter ended* March 31, 2024,none of our officers or directors, as defined in Rule16a*-1(f), informed us of the adoption or termination of a Rule10b5-1 trading arrangement or a non-Rule10b5-1 trading arrangement, each as defined in Regulation S-K Item408.
56
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.